These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7004292)

  • 1. Reflux esophagitis: effect of oral bethanechol on symptoms and endoscopic findings.
    Thanik KD; Chey WY; Shah AN; Gutierrez JG
    Ann Intern Med; 1980 Dec; 93(6):805-8. PubMed ID: 7004292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind controlled trial of bethanechol and antacid versus placebo and antacid in the treatment of erosive esophagitis.
    Saco LS; Orlando RC; Levinson SL; Bozymski EM; Jones JD; Frakes JT
    Gastroenterology; 1982 Jun; 82(6):1369-73. PubMed ID: 7040158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bethanechol or cimetidine in the treatment of symptomatic reflux esophagitis: a double-blind control study.
    Thanik K; Chey WY; Shak A; Hamilton D; Nadelson N
    Arch Intern Med; 1982 Aug; 142(8):1479-81. PubMed ID: 6125135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of long-term medical treatment with cimetidine and bethanechol in patients with esophagitis and Barrett's esophagus.
    Humphries TJ
    J Clin Gastroenterol; 1987 Feb; 9(1):28-32. PubMed ID: 2881958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cimetidine versus antacid in scleroderma with reflux esophagitis. A randomized double-blind controlled study.
    Petrokubi RJ; Jeffries GH
    Gastroenterology; 1979 Oct; 77(4 Pt 1):691-5. PubMed ID: 381093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sucralfate used as adjunctive therapy in patients with severe erosive peptic esophagitis resulting from gastroesophageal reflux.
    Herrera JL; Shay SS; McCabe M; Peura DA; Johnson LF
    Am J Gastroenterol; 1990 Oct; 85(10):1335-8. PubMed ID: 2220725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sucralfate versus placebo in reflux esophagitis. A double-blind multicenter study.
    Carling L; Cronstedt J; Engqvist A; Kagevi I; Nyström B; Svedberg LE; Thorhallsson E; Unge P; Wingren PE
    Scand J Gastroenterol; 1988 Nov; 23(9):1117-24. PubMed ID: 3073524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral cimetidine in reflux esophagitis: a double blind controlled trial.
    Wesdorp E; Bartelsman J; Pape K; Dekker W; Tytgat GN
    Gastroenterology; 1978 May; 74(5 Pt 1):821-4. PubMed ID: 346430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gastroesophageal reflux disease and reflux esophagitis. Therapeutic modifiability by bethanechol chloride].
    Hunold W
    ZFA (Stuttgart); 1982 Oct; 58(29):1623-8. PubMed ID: 6129755
    [No Abstract]   [Full Text] [Related]  

  • 10. Medical management of reflux esophagitis.
    Vantrappen G; Janssens J
    Digestion; 1985; 32 Suppl 1():51-8. PubMed ID: 2866136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cimetidine treatment of reflux esophagitis: results of a double-blind study].
    Sonnenberg A; Lepsien G; Berges W; Weber KB; Wienbeck M; Siewert JR; Blum AL
    Schweiz Med Wochenschr; 1979 Apr; 109(16):613-5. PubMed ID: 373103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of severe reflux esophagitis with cimetidine and metoclopramide.
    Lieberman DA; Keeffe EB
    Ann Intern Med; 1986 Jan; 104(1):21-6. PubMed ID: 3940501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of reflux oesophagitis. A randomized, controlled evaluation of cimetidine.
    Breen KJ; Desmond PV; Whelan G
    Med J Aust; 1983 Nov; 2(11):555-8. PubMed ID: 6355792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled trial of a new dosage form of carbenoxolone (Pyrogastrone) in the treatment of reflux esophagitis.
    Reed PI; Davies WA
    Am J Dig Dis; 1978 Feb; 23(2):161-5. PubMed ID: 341689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of different doses of cimetidine in the treatment of reflux esophagitis. A review of three large, double-blind, controlled trials.
    Tytgat GN; Nicolai JJ; Reman FC
    Gastroenterology; 1990 Sep; 99(3):629-34. PubMed ID: 2199289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current concepts in the pathogenesis and treatment of reflux esophagitis.
    Frazier JL; Fendler KJ
    Clin Pharm; 1983; 2(6):546-57. PubMed ID: 6360495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of reflux oesophagitis with ranitidine.
    Wesdorp IC; Dekker W; Klinkenberg-Knol EC
    Gut; 1983 Oct; 24(10):921-4. PubMed ID: 6311693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoscopically controlled trial of alginate and antacid in reflux oesophagitis.
    Scobie BA
    Med J Aust; 1976 Apr; 1(17):627-8. PubMed ID: 778564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease.
    Armstrong D; Paré P; Pericak D; Pyzyk M;
    Am J Gastroenterol; 2001 Oct; 96(10):2849-57. PubMed ID: 11695354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical therapy for reflux esophagitis: 1986 and beyond.
    Castell DO
    Ann Intern Med; 1986 Jan; 104(1):112-4. PubMed ID: 2866742
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.